This is a routine Form 144 filing following RSU vesting. The sale amount is small relative to the company's market cap and the insider's likely total holdings. Monitor for any subsequent Form 4 filings to confirm execution, but no material impact is expected.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 11 $81.17entry
- T+1 · 5d ago −1.68%α −1.32% · $79.81
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Jeffrey Novack, an officer of CareDx, filed a Form 144 notice of intent to sell 4,096 shares of common stock, with an approximate market value of $345,784. The shares were acquired through vesting of restricted stock units between November 1 and November 6, 2026. This is a routine insider sale following equity vesting, representing a small fraction of the company's $4.1B market cap.
Key Facts
- Reporting person: Jeffrey Novack, an officer of CareDx
- Shares to be sold: 4,096 shares of common stock
- Estimated value: $345,784 (based on approximate price of $84.42 per share)
- Shares acquired via vesting of restricted stock units from November 1 to November 6, 2026
- Proposed sale date: November 10, 2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
Financial Impact
Sale of 4,096 shares valued at approximately $345,784, representing less than 0.01% of CareDx's $4.1B market cap
Risk Factors
- Insider sale may signal lack of confidence, though the small size and RSU vesting context mitigate this concern
- Form 144 is an intent to sell; the actual sale may not occur
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010944 |
| Document: 0001950047-26-010944-index.html | 0001950047-26-010944 |
| Document: 0001950047-26-010944.txt | 0001950047-26-010944 |
Track record
16 reports on CDNA
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +28.28% at T+60 after the Apr 16, 2026 report. 3 of 5 went positive at some point.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $77.88 Now $73.72 −5.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $77.88 Now $73.72 −5.34% settles Feb 11
- Nov 10, 20266d ago 144 Neutral 2/10 Viewing Entry $81.17 Now $73.72 −9.18% settles Feb 9
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $80.77 Now $73.72 −8.73% settles Feb 8
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $78.56 Now $73.72 −6.16% settles Feb 4
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $87.41 Now $73.72 −15.66% settles Jan 28
- Oct 29, 202618d ago Institutional Cluster Bearish 4/10 Entry $71.52 Now $73.72 −3.08% settles Jan 27
- Aug 6, 202614w ago Insider Cluster Neutral 3/10 Entry $46.69 to $86.54 Now $73.72 +57.89% ▲ +85.34% +87.47% vs SPY
- Aug 4, 202614w ago 144 Neutral 2/10 Entry $45.50 Now $73.72 +62.02% No price data
- Jul 17, 202617w ago Insider Cluster Neutral 4/10 Entry $39.73 Now $73.72 +85.55% No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers